Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βII

22Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

The signaling output of protein kinase C (PKC) is exquisitely controlled, with its disruption resulting in pathophysiologies. Identifying the structural basis for autoinhibition is central to developing effective therapies for cancer, where PKC activity needs to be enhanced, or neurodegenerative diseases, where PKC activity should be inhibited. Here, we reinterpret a previously reported crystal structure of PKCβII and use docking and functional analysis to propose an alternative structure that is consistent with previous literature on PKC regulation. Mutagenesis of predicted contact residues establishes that the Ca2+-sensing C2 domain interacts intramolecularly with the kinase domain and the carboxyl-terminal tail, locking PKC in an inactive conformation. Ca2+-dependent bridging of the C2 domain to membranes provides the first step in activating PKC via conformational selection. Although the placement of the C1 domains remains to be determined, elucidation of the structural basis for autoinhibition of PKCβII unveils a unique direction for therapeutically targeting PKC.

Cite

CITATION STYLE

APA

Antal, C. E., Callender, J. A., Kornev, A. P., Taylor, S. S., & Newton, A. C. (2015). Intramolecular C2 Domain-Mediated Autoinhibition of Protein Kinase C βII. Cell Reports, 12(8), 1252–1260. https://doi.org/10.1016/j.celrep.2015.07.039

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free